Delivering next-generation treatments for back of the eye disorders, with focus on diabetic eye disease

Regulated information - Transparency Statement OXUR shares

10 May 2019

Regulated Information - Transparency Statement

Disclosure in accordance with Belgian Law of 2 May 2007 – Transparency Law

Leuven, Belgium, 10 May 2019 – Pursuant to article 15 of the Belgian Law of 2 May 2007 regarding the publication of major holdings. Oxurion NV (Euronext Brussel: OXUR) publishes the following information:
Status as of 8 November 2018
• Total capital: € 147.976.946,87
• Total number of securities conferring voting rights: 38,291,950 shares
• Total number of voting rights (denominator): 38,291,950 (one vote per share)

Reason of change
Capital increase on 8 November 2018, creation of new 20.375 shares following the exercising of warrants
For an overview of the history of capital, please consult the Oxurion company website at https://www.oxurion.com/investors/shareholder-info/history-capital

Press release attachment: 
Tags: 
Investors; Company